Glycosphingolipid synthesis inhibitor AMP.DNM lowers plasma cholesterol levels by promoting fecal cholesterol excretion without inhibiting cholesterol absorption

References

• Ross R. Atherosclerosis – an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).
   Google Scholar
• Worgall TS. Sphingolipids: major regulators of lipid metabolism. Curr. Opin Clin. Nutr. Metab. Care 10, 149–155 (2007).
   Google Scholar
• Bismuth J, Lin P, Yao Q, Chen C. Ceramide: a common pathway for atherosclerosis? Atherosclerosis 196, 497–504 (2008).
   Google Scholar
• Mukhin DN, Chao FF, Kruth HS. Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1607–1615 (1995).
   Google Scholar
• Nelson JC, Jiang XC, Tabas I, Tall A, Shea S. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 163, 903–912 (2006).
   Google Scholar
• Jiang XC, Paultre F, Pearson TA et al. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 20, 2614–2618 (2000).
   Google Scholar
• Schlitt A, Hojjati MR, von GH et al. Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles. J. Lipid Res. 46, 196–200 (2005).
   Google Scholar
• Dawson G, Kruski AW, Scanu AM. Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. J. Lipid Res. 17, 125–131 (1976).
   Google Scholar
• Chatterjee S, Kwiterovich PO. Glycosphingolipids of human plasma lipoproteins. Lipids 11, 462–466 (1976).
   Google Scholar
• Bijl N, van Roomen CP, Triantis V et al. Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice. Hepatology 49, 637–645 (2009).
   Google Scholar
• Aerts JM, Ottenhoff R, Powlson AS et al. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 56, 1341–1349 (2007).
   Google Scholar
• Bijl N, Sokolovic M, Vrins C et al. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. Hepatology 50, 1431–1441 (2009).
   Google Scholar
• van Eijk M, Aten J, Bijl N et al. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. PLoS ONE 4, e4723 (2009).
   Google Scholar
• Groen AK, Oude Elferink RP, Verkade HJ, Kuipers F. The ins and outs of reverse cholesterol transport. Ann. Med. 36, 135–145 (2004).
   Google Scholar
• van der Velde V, Vrins CL, van den Oever K et al. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology 133, 967–975 (2007).
   Google Scholar
• Garmy N, Taieb N, Yahi N, Fantini J. Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. J. Lipid Res. 46, 36–45 (2005).
   Google Scholar
• Altmann SW, Davis HR, Zhu LJ et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201–1204 (2004).
   Google Scholar
• Kosoglou T, Statkevich P, Johnson- Levonas AO, Paolini JF, Bergman AJ, Alton KB. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin. Pharmacokinet. 44, 467–494 (2005).
   Google Scholar
• Davis HR, Compton DS, Hoos L, Tetzloff G. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arterioscler. Thromb. Vasc. Biol. 21, 2032–2038 (2001).
   Google Scholar
• Huang H, Kauan JW, Guilbault GG. Fluorometric enzymatic determination of total cholesterol in serum. Clin. Chem. 21, 1605–1608 (1975).
   Google Scholar
• Levels JH, Pajkrt D, Schultz M. Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim. Biophys. Acta 1771, 1429–1438 (2007).
   Google Scholar
• Gerhardt KO, Gehrke CW, Rogers IT, Flynn MA, Hentges DJ. Gas–liquid chromatography of fecal neutral steriods. J. Chromatogr. 135, 341–349 (1977).
   Google Scholar
• Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509 (1957).
   Google Scholar
• Vrins CL, van der Velde V, van den Oever K et al. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J. Lipid Res. 50(10), 2046–2054 (2009).
   Google Scholar
• Brown JM, Bell TA 3rd, Alger HM et al. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J. Biol. Chem. 283, 10522–10534 (2008).
   Google Scholar
• Repa JJ, Turley SD, Quan G, Dietschy JM. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J. Lipid Res. 46, 779–789 (2005).
   Google Scholar
• Valasek MA, Weng J, Shaul PW, Anderson RG, Repa JJ. Caveolin?1 is not required for murine intestinal cholesterol transport. J. Biol. Chem. 280, 28103–28109 (2005).
   Google Scholar
• van der Velde AE, Vrins CL, van den Oever K et al. Regulation of direct transintestinal cholesterol excretion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G203–G208 (2008).
   Google Scholar
• van der Veen JN, van Dijk TH, Vrins CL et al. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. J. Biol. Chem. 284, 19211–19219 (2009).
   Google Scholar
• Reczek D, Schwake M, Schroder J et al. LIMP?2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 131, 770–783 (2007).
   Google Scholar
• Storey SM, McIntosh AL, Huang H et al. Intracellular cholesterol binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. doi:10.1152/ajpgi.00195.2012 (2012) (Epub ahead of print).
   Google Scholar
• Altmann SW, Davis HR Jr, Yao X et al. The identification of intestinal scavenger receptor class B, type I (SR?BI) by expression cloning and its role in cholesterol absorption. Biochim. Biophys. Acta 1580(1), 77–93 (2002).
   Google Scholar
• Fabbri G, Maggioni AP. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Adv. Ther. 26, 469–487 (2009).
   Google Scholar
• Brautbar A, Ballantyne CM. Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nat. Rev. Cardiol. 8, 253–265 (2012).
   Google Scholar
• Paciaroni M, Bogousslavsky J. Statins and stroke prevention. Expert Rev. Cardiovasc. Ther. 7, 1231–1243 (2009).
   Google Scholar